Carl Zeiss Meditec AG annual ebitda
2022
2023
2024
2025
Carl Zeiss Meditec AG EBITDA Growth & History (AFX)
Carl Zeiss Meditec AG's calculated EBITDA was €349.7M for fiscal 2025.
View full Carl Zeiss Meditec AG company overviewCarl Zeiss Meditec AG annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | €349.7M | €22.5M | +6.87% |
| 2024 | 2024-09-30 | €327.2M | −€95.0M | −22.49% |
| 2023 | 2023-09-30 | €422.2M | −€44.5M | −9.53% |
| 2022 | 2022-09-30 | €466.6M | — | — |
Carl Zeiss Meditec AG quarterly ebitda
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2025-12-31 | €2.0M | −€25.0M | −92.59% |
| Q4 2025 | 2025-09-30 | €73.5M | — | — |
| Q3 2025 | 2025-06-30 | €47.7M | — | — |
| Q2 2025 | 2025-03-31 | €72.4M | — | — |
| Q1 2025 | 2024-12-31 | €27.0M | — | — |
Carl Zeiss Meditec AG ebitda trends
Between the periods ended 2022-09-30 and 2025-09-30, Carl Zeiss Meditec AG's ebitda decreased from €466.6M to €349.7M, a change of −€117.0M. The latest reported quarter, Q1 2026, shows €2.0M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Carl Zeiss Meditec AG source filings ↗